Type I insulin-like growth factor as a liver reserve assessment tool in hepatocellular carcinoma

Chronic liver diseases (CLDs) encompass a wide range of illnesses, including nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and viral hepatitis. Deterioration of liver capacity, with subsequent progression into cirrhosis and hepatocellular carcinoma (HCC), ultimately leads to a furt...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Hepatocell Carcinoma
Auteurs principaux: Abdel-Wahab, Reham, Shehata, Samir, Hassan, Manal M, Habra, Mouhammed A, Eskandari, Ghazaleh, Tinkey, Peggy T, Mitchell, Jennifer, Lee, Ju-Seog, Amin, Hesham M, Kaseb, Ahmed O
Format: Artigo
Langue:Inglês
Publié: Dove Medical Press 2015
Sujets:
Review
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4918293/
https://ncbi.nlm.nih.gov/pubmed/27508202
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JHC.S81309
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires